previous compound ID: 2226 next compound
InChIKey: ULGZDMOVFRHVEP-RWJQBGPGSA-N
SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "E Matthes" "JW Hanrahan" "J Liao" "D Rotin" "DY Thomas" "J Goepp" "B Kus" "SD Macknight" "R Robert"

chemical graph of compound 2226





CID is 12560
synonyms found at PubChem are:
erythromycin, Erythromycin A, 114-07-8, E-Mycin, Abomacetin, Erythrocin, Erythromycinum, Erymax, Ilotycin, Erythromycine, Eritromicina, Emgel, Erycette, Robimycin, Erythro-Statin, E-Glades, Ery-Tab, E-Base, erythro, Benzamycin, Dumotrycin, Erythrogran, Mephamycin, Stiemycin, Ermycin, Eryacne, Erycen, Erygel, Sansac, Aknin, Wemid, Eryc Sprinkles, Erythra-Derm, Theramycin Z, Akne-Mycin, Erythromycin base, Ak-Mycin, Erythromast 36, R-P Mycin, Endoeritrin, Eritomicina, Erythroderm, Erytrociclin, Paediathrocin, Pharyngocin, Proterytrin, Acneryne, Acnesol, Aknemycin, Derimer, Deripil, Erisone, Eryacnen, Erydermer, Eryhexal, Erysafe, Iloticina, Latotryd, Lederpax, Mercina, Oftamolets, Pantoderm, Pantodrin, Primacine, Romycin, Stiemicyn, Tiloryth, Tiprocin, Emuvin, Erecin, Erymed, Erytop, E-Solve 2, AustriaS, Eros, Ery-maxin, Erythro-Teva, Sans-acne, Torlamicina, Abboticin, Erimycin-T, Ery-Diolan, Inderm Gel, Del-Mycin, Aknederm Ery Gel, Udima Ery Gel, Eryc 125, Emu-Ve, Skid Gel E, Akne Cordes Losung, Ilosone (estolate), Ilotycin T.S., E-Mycin (base), Ery-Tab (base), E-Base (base), Emu-V, Ery-B, ERYC (base), Erythroguent, C-Solve-2, Eritrocina, Erycinum, Erythromid, Pantomicina, Propiocine, Dotycin, Erycin, Eryderm, Ilocaps, N-Methylerythromycin A, ERYC, Pfizer-E, PCE Dispertab (base), IndermRetcin, Kesso-Mycin, Taimoxin-F, Eryc-125, Eryc-250, Erythromycin Lactate, T-Stat, Ery-Sol, Eritromicina [INN-Spanish], Erythromycine [INN-French], Erythromycinum [INN-Latin], Oftalmolosa Cusi Eritromicina, Staticin (TN), Akne-mycin (TN), Emycin, Erytab, Inderm, Retcin, Erygel (TN), UNII-63937KV33D, Wyamycin S, Eryc (TN), T-stat (TN), Erythrocin stearate, Pce (TN), (-)-ERYTHROMYCIN, CHEMBL532, ERYTHROMYCIN STEARATE, erythromycin-A, Benzamycin Pak, CHEBI:42355, ULGZDMOVFRHVEP-RWJQBGPGSA-N, A/T/S, 63937KV33D, Ilotycin gluceptate, NCI-C55674, E0751, DSSTox_CID_2991, DSSTox_RID_76820, DSSTox_GSID_22991, (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione, ERY, Erythromycin [INN:BAN:JAN], CCRIS 9078, Erythromycin glucoheptonate, HSDB 3074, Ilotycin T.S, EINECS 204-040-1, Erythromycin Ointment, NSC 55929, Erythromycin intravenous, (2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3-amino-3,4,6-trideoxy-N,N-dimethyl--D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C,3-O-dimethyl--L-ribo-hexopyranosyloxy)-13-ethyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxotridecan-13-olide, AI3-50138, E-mycin, Erycin, Robimysin, SR-05000001618, Sentry AQ mardel maracyn, erthromycin, Erythromycin sodium lauryl sulfate, Erythromycines, ULGZDMOVFRHVEP-UHFFFAOYSA-N, NSC55929, NCGC00094670-01, Erythromycin [USP:INN:BAN:JAN], 82343-12-2, adecane-2,10-dione (non-preferred name), CAS-114-07-8, Prestwick_205, E-mycin, Erythrocin, Spectrum_000115, Spectrum_000659, AC1L1ZUR, EM-A, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,, Prestwick3_000151, Spectrum2_000759, Spectrum2_001263, Spectrum4_000538, Spectrum5_001596, Erythromycin A, B + C, D02YIZ, EC 204-040-1, Erythromycin & VRC3375, SCHEMBL2601, BSPBio_000282, BSPBio_002480, KBioGR_001175, KBioSS_000555, KBioSS_001139, MLS001066618, BIDD:GT0017, DivK1c_000294, DivK1c_000397, DivK1c_000702, SPECTRUM1500280, SPBio_000778, SPBio_001226, Erythromycin (mixture A,B,C), BPBio1_000312, GTPL1456, CHEMBL3735423, DTXSID4022991, Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279, Erythromycin (JP15/USP/INN), Erythromycin (JP17/USP/INN), HMS500O16, KBio1_000294, KBio1_000397, KBio1_000702, KBio2_000555, KBio2_001139, KBio2_003123, KBio2_003707, KBio2_005691, KBio2_006275, MolPort-002-507-378, NINDS_000294, NINDS_000397, NINDS_000702, ZX-AFC000696, HMS1920M04, HMS2091D05, HMS2095O04, HMS3712O04, Pharmakon1600-01500280, ACT03320, HY-B0220, RKL10096, Tox21_111311, Tox21_111869, Tox21_300515, BDBM50344942, CCG-38992, LMPK04000006, MFCD00084654, NSC756759, ZINC85534336, AKOS015895249, CS-2168, DB00199, MCULE-4566208867, NSC-756759, IDI1_000294, IDI1_000397, IDI1_000702, SMP1_000119, NCGC00179619-01, NCGC00179619-02, NCGC00179619-03, NCGC00254234-01, AC-12744, AC-12901, BC205124, CC-27517, CPD000544946, SAM002643510, SC-13736, SMR000544946, Erythromycin, potency: >=850 mug per mg, Erythromycin, tested according to Ph.Eur., SBI-0051368.P003, Erythromycin, N-demethyl-N-(methyl-11C)-, LS-187077, Erythromycin, meets USP testing specifications, C01912, D00140, E-3250, Erythromycin, plant cell culture tested, ~98%, 44496-EP2272846A1, 44496-EP2275422A1, 44496-EP2292608A1, 44496-EP2305644A1, 44496-EP2308866A1, 44496-EP2311814A1, 44496-EP2311828A1, 44496-EP2380568A1, AB00051981_09, AB00051981_10, Erythromycin standard solution, 1 mg/mL in H2O, Erythromycin, Biotechnology Performance Certified, 114E078, C-23475, SR-01000799155, 9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, Erythromycin, Antibiotic for Culture Media Use Only, Erythromycin, BioReagent, suitable for cell culture, SR-01000799155-2, SR-05000001618-1, SR-05000001618-2, BRD-K63550407-001-13-5, BRD-K63550407-028-03-9, Erythromycin, compd. with monododecyl sulfate, sodium salt, Erythromycin A, European Pharmacopoeia (EP) Reference Standard, Erythromycin, United States Pharmacopeia (USP) Reference Standard, Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin, Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard, Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material, (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, 374700-25-1